Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Journal of Advances in Medicine and Pharmaceutical Sciences
Quennerstedt, Joakim
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Medicine & Pharmacology Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Navigating the Rise of Cannabidiol: Trends, Challenges, and Future Directions Johansson, Erik; Quennerstedt, Joakim; Langer, Anneli Eva; Kullander, Stenberg
Journal of Advances in Medicine and Pharmaceutical Sciences Vol 4 No 1: May 2025
Publisher : Lamintang Education and Training Centre, in collaboration with the International Association of Educators, Scientists, Technologists, and Engineers (IA-ESTE)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36079/lamintang.jamaps-0401.771

Abstract

The use of cannabidiol (CBD) as an alternative treatment for chronic pain and anxiety is experiencing a rapid rise in Sweden. This study explores current trends, patient and healthcare provider perceptions, regulatory challenges, and barriers to broader CBD adoption. Employing a mixed-methods design, quantitative surveys and qualitative interviews are conducted with CBD users and healthcare professionals across various regions in Sweden. Findings indicate that CBD usage is highest in urban areas, driven by greater accessibility and wellness culture. Patients report moderate to high satisfaction, particularly for chronic pain management, although self-medication practices and lack of professional guidance are common. Healthcare providers exhibit cautious optimism, citing the need for further clinical validation and regulatory clarity. Safety concerns such as inaccurate product labeling and financial barriers, including the absence of insurance coverage for CBD, emerge as significant obstacles. Demographic analysis reveals differing usage patterns based on age but minimal gender differences. The study highlights the urgent need for standardized dosing guidelines, rigorous randomized controlled trials (RCTs), and stronger regulatory frameworks to ensure quality and equity in CBD treatment. Sweden’s progressive healthcare landscape positions it to play a leading role in global efforts to integrate CBD responsibly into mainstream medicine. Future research must bridge clinical, regulatory, and economic gaps to support CBD’s evolution as a legitimate therapeutic option worldwide.
Co-Authors Johansson, Erik Kullander, Stenberg Langer, Anneli Eva